Condition (MeSH)
Duodenal Obstruction
ClinicalTrials.gov lists 9 trials for Duodenal Obstruction or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
5 of the 9 trials are tagged with Duodenal Obstruction itself; the rest are tagged with a narrower condition beneath it.
When did Duodenal Obstruction trials start? (7)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here.
Trials over time, by phase
- Phase 3
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2025 | 1 |
| 2024 | 2 |
| 2020 | 1 |
| 2017 | 1 |
| 2009 | 1 |
| 2008 | 1 |
| 2007 | 1 |
No forecast is made for this condition: it averages 0.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Duodenal Obstruction trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 3 | 1 |
| Not applicable | 5 |
| Observational | 3 |
How many Duodenal Obstruction trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 2 |
| Completed | 5 |
| Terminated | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Duodenal Obstruction trials? (4)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Cogentus Pharmaceuticals | 1 |
| Cook Group Incorporated | 1 |
| GT Metabolic Solutions, Inc. | 1 |
| University Hospital, Angers | 1 |
Which publications cover Duodenal Obstruction? (19)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| International study of endoscopic management of distal malignant biliary obstruction combined with duodenal obstruction. | Scandinavian journal of gastroenterology | 2018 | Yes |
| Natural orifice transluminal endoscopic surgery gastroenterostomy with a biflanged lumen-apposing stent: first clinical experience (with videos). | Gastrointestinal endoscopy | 2015 | Yes |
| Percutaneous biliary covered stent insertion in patients with malignant duodenobiliary obstruction. | Acta radiologica (Stockholm, Sweden : 1987) | 2015 | Yes |
| Endoscopic bilio-duodenal bypass: outcomes of primary and revision efficacy of combined metallic stents in malignant duodenal and biliary obstructions. | Digestive diseases and sciences | 2014 | Yes |
| Tumor overgrowth after expandable metallic stent placement: experience in 583 patients with malignant gastroduodenal obstruction. | AJR. American journal of roentgenology | 2011 | Yes |
Showing 5 of 19 publications.
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, and rare-disease identity.
Not computed for conditions with fewer than 10 trials: drugs tested.